Clinical Trial Update: Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term safety and efficacy of WC3011 (estradiol vaginal cream) for vulvovaginal atrophy; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• WC3011 (estradiol vaginal cream)

Snippet

Sponsor: Warner Chilcott | Conditions: Vulvovaginal Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2022-05-09